Top Markets
Coin of the day
BG Medicine, Inc. BG Medicine, Inc.

BG Medicine, Inc.

BGMD
Rang in Aktien #42481
BG Medicine, Inc. is dedicated to the development and commercialization of... BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$1.14K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel BG Medicine, Inc. (BGMD)

Kategorie

Kursverlauf für BG Medicine, Inc. (BGMD)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $33.28 am 2011-02-01
Kursverlauf der Aktie von BG Medicine, Inc. von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -9.46%
2024 -9.43%
2023 -69.12%
2022 223.81%
2021 -99.74%
2020 287.26%
2019 -54.23%
2018 -48.32%
2017 -33.28%
2016 -88.44%
2015 -62.26%
2014 -60.09%
2013 -60.12%
2012 -46.91%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$401.71 -15.99%
US
$195.00 -34.20%
FR
$169.70 26.86%
JP
$183.17 19.50%
US
$77.02 -10.27%
CH